Mesoblast (MESO, $15.41) was a top loser this month, diving -2 to $15.41 per share. Of the 852 stocks analyzed in the Biotechnology Industry throughout this month, of them (2) exhibited an Uptrend while of them (7) were in a Downtrend. A.I.dvisor found 363 similar cases when MESO's price dropped within one month. In out of those 363 cases, MESO's price continued to decline in the subsequent month. Based on this historical data, A.I. thinks the odds of a Downtrend continuation for MESO are